Search Results: Prevention, Detection & Risk + Breast Cancer (4 results)
The WISDOM Study: Women Informed to Screen Depending on Measures of Risk
https://www.facingourrisk.org/research-clinical-trials/study/45/wisdom-study
Prevention
Genetic testing and breast cancer screening
The goal of the Wisdom Study is to determine if breast cancer screening can be made better by personalizing each woman’s mammogram schedule, compared to the current one-size-fits-all, annual approach. The Wisdom Study is designed to end the confusion about when to start and how often to have a mammogram.
Helping Latinas Understand Their Risk for Breast Cancer and Get Breast Cancer Care
https://www.facingourrisk.org/research-clinical-trials/study/250/helping-latinas-understand-their-risk-for-breast-cancer-and-get-breast-cancer-care
Prevention
Latinas with a high risk of breast cancer
This study will teach Latinas with a high risk of breast cancer about how diet, exercise, ethnicity, genetics and screening and prevention guidelines may impact their likelihood for developing breast cancer. The study will test ways of teaching participants about breast cancer and risk factors, comparing the current standard of care to new personal educational sessions. Bilingual and bicultural staff are available for the phone study to make the study open to both English and Spanish speakers.
Serum Biomarkers to Characterize the Effects of Therapy on Ovarian Reserve in Premenopausal Women With Early-stage Breast Cancer or BRCA Mutations
https://www.facingourrisk.org/research-clinical-trials/study/109/blood-tests-to-measure-ovarian-reserves-in-women-with-a-brca-mutation-or-women-treated-for-early-stage-breast-cancer
Prevention
Study for premenopausal women with early-stage breast cancer and high-risk women with BRCA mutations and no evidence of breast or ovarian cancer
The purpose of this study is to see how cancer treatment affects the ovaries, such as the impact on conceiving a child or the early onset of menopause. Comparatively, the study will also look at high-risk women with BRCA1/2 mutations (and no evidence of breast or ovarian cancer).
The study will check blood levels of hormones that the ovaries produce and will use questionnaires to gather information about participant menstrual cycles, health, and pregnancies.
Genomic Services Research Program Study for People with Unexpected Genetic Results
https://www.facingourrisk.org/research-clinical-trials/study/89/study-for-people-with-unexpected-genetic-results
Prevention
Study for people who received unexpected genetic test results about their cancer risk after having genetic testing done for some other reason
A new study is recruiting people who received unexpected genetic test results about their cancer risk after having genetic testing done for some other reason.
This is a study of people with "secondary results” from genetic testing. Secondary results are unexpected. They are not related to the reason the person had the genetic test but are shared because they may be very important to the person’s health. Most secondary results have to do with high risks for health problems that can be treated or prevented. Many of these results are related to cancer risk. If you think you have received a secondary result, you may be eligible to join this study.
Additional Results on Clinicaltrials.gov Prevention, Detection & Risk + Breast Cancer
38 results
Delayed Sentinel Lymph Node Biopsy in Ductal Cancer in Situ
NCT ID: NCT04722692 (https://clinicaltrials.gov/study/NCT04722692)
A Multi-Modality Surveillance Program for Women at High Risk for Breast Cancer
NCT ID: NCT03729115 (https://clinicaltrials.gov/study/NCT03729115)
The C-MERIT Screening Cohort: Contrast-enhanced Mammography for Breast Cancer Screening and Risk Assessment in Women With Dense Breasts
NCT ID: NCT05667532 (https://clinicaltrials.gov/study/NCT05667532)
Impact of Dietary Inflammatory Potential on Breast Cancer Risk
NCT ID: NCT05178498 (https://clinicaltrials.gov/study/NCT05178498)
Connecting Black Families in Houston, Texas to Hereditary Cancer Genetic Counseling, Genetic Testing, and Cascade Testing by Using a Simple Genetic Risk Screening Tool and Telegenetics
NCT ID: NCT05694559 (https://clinicaltrials.gov/study/NCT05694559)
Comparison of Synthetic Mammography Versus Full-Field Digital Mammography in Image Interpretation and Performance Metrics
NCT ID: NCT05056818 (https://clinicaltrials.gov/study/NCT05056818)
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NCT ID: NCT05625659 (https://clinicaltrials.gov/study/NCT05625659)
Cone Beam Breast CT for Breast Cancer Screening
NCT ID: NCT05036096 (https://clinicaltrials.gov/study/NCT05036096)
Accurate, Rapid and Inexpensive MRI Protocol for Breast Cancer Screening
NCT ID: NCT04877912 (https://clinicaltrials.gov/study/NCT04877912)
Testing Conversation Aid in Practice
NCT ID: NCT06011434 (https://clinicaltrials.gov/study/NCT06011434)
Breast Cancer Screening Adherence for Women at Moderate Risk for Breast Cancer
NCT ID: NCT07076147 (https://clinicaltrials.gov/study/NCT07076147)
A Validation Study to Determine Concordance of Liquid Biopsy and Breast Cancer Diagnosis
NCT ID: NCT06336928 (https://clinicaltrials.gov/study/NCT06336928)
Evaluating an Evidence-Based Family History Screening Program Adapted to Increase Reach and Uptake of Screening for BRCA-Associated Cancers in Rural Public Health Clinics
NCT ID: NCT06760507 (https://clinicaltrials.gov/study/NCT06760507)
Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib
NCT ID: NCT04614194 (https://clinicaltrials.gov/study/NCT04614194)
Faith in Action! A Church-Based Navigation Model to Increase Breast Cancer Screening in Korean Women
NCT ID: NCT05298605 (https://clinicaltrials.gov/study/NCT05298605)
CONTIGO - A Narrative Intervention to Enhance Genetic Counseling and Testing
NCT ID: NCT05130606 (https://clinicaltrials.gov/study/NCT05130606)
National Mammography Database
NCT ID: NCT01900821 (https://clinicaltrials.gov/study/NCT01900821)
MADRE (Mammograms Available Due to Research and Education)
NCT ID: NCT05841355 (https://clinicaltrials.gov/study/NCT05841355)
Testing a Mammography Decision Intervention in a Rural Setting
NCT ID: NCT06522568 (https://clinicaltrials.gov/study/NCT06522568)
Magnetic Resonance Imaging of Breast Cancer
NCT ID: NCT01035112 (https://clinicaltrials.gov/study/NCT01035112)
FHIR-Enhanced RealRisks to Improve Accuracy of Breast Cancer Risk Assessments
NCT ID: NCT05810025 (https://clinicaltrials.gov/study/NCT05810025)
Biennial CEM in Women With a Personal History of Breast Cancer
NCT ID: NCT06105749 (https://clinicaltrials.gov/study/NCT06105749)
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
NCT ID: NCT05968157 (https://clinicaltrials.gov/study/NCT05968157)
Rutgers University Study of the Genetics of Breast Cancer.
NCT ID: NCT06773897 (https://clinicaltrials.gov/study/NCT06773897)
Identification of Breast Cancer in Breath Samples Using Trained Detection Dogs
NCT ID: NCT07038785 (https://clinicaltrials.gov/study/NCT07038785)
With Love, Grandma ("Con Cariño, Abuelita") Pilot Study
NCT ID: NCT05721976 (https://clinicaltrials.gov/study/NCT05721976)
Long-term Safety of Nipple Sparing Mastectomy in Women With High Penetrance Breast Cancer Susceptibility Genes in Breast Cancer
NCT ID: NCT06888388 (https://clinicaltrials.gov/study/NCT06888388)
Early Detection of Breast Cancer
NCT ID: NCT06043661 (https://clinicaltrials.gov/study/NCT06043661)
DCIS: RECAST Trial Ductal Carcinoma In Situ: Re-Evaluating Conditions for Active Surveillance Suitability as Treatment
NCT ID: NCT06075953 (https://clinicaltrials.gov/study/NCT06075953)
Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer
NCT ID: NCT04030507 (https://clinicaltrials.gov/study/NCT04030507)
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
NCT ID: NCT07121972 (https://clinicaltrials.gov/study/NCT07121972)
Evaluation of the Bexa Breast Examination
NCT ID: NCT06643767 (https://clinicaltrials.gov/study/NCT06643767)
Contrast-enhanced Spectral Mammography (CESM) Breast Cancer Screening
NCT ID: NCT04904757 (https://clinicaltrials.gov/study/NCT04904757)
Implementation and Effectiveness of the BJC-Pink and Pearl Project on Lung Cancer Screening
NCT ID: NCT06898333 (https://clinicaltrials.gov/study/NCT06898333)
Physical Activity Targeting Metabolic Syndrome for Prevention of Breast Cancer in SAI Women
NCT ID: NCT06827704 (https://clinicaltrials.gov/study/NCT06827704)
Developing and Evaluating Culturally Relevant Interventions to Improve Breast Cancer Screening
NCT ID: NCT05665660 (https://clinicaltrials.gov/study/NCT05665660)
Abbreviate or FAST Breast MRI for Supplemental Breast Cancer Screening for Black Women at Average Risk and Dense Breasts
NCT ID: NCT04854304 (https://clinicaltrials.gov/study/NCT04854304)
Empowering Vulnerable and Resilient Latinas to Obtain Breast Cancer Care
NCT ID: NCT05483283 (https://clinicaltrials.gov/study/NCT05483283)
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.